Clarity Pharmaceuticals

Clarity Pharmaceuticals is a personalised medicine company focused on the treatment of serious disease. The company is a leader in innovative radiopharmaceutical technology, developing targeted therapies and assisting in the drug development pipeline of novel therapies for companies globally. Established in 2010 as a private, Sydney-based life sciences company, Clarity utilises its imaging capability to produce safer and more effective patient outcomes. Clarity’s platform technology, developed in collaboration with the Australian Nuclear Science and Technology Organisation (ANSTO) and the University of Melbourne, allows biopharmaceuticals to be radiolabeled and visualised using PET imaging. The imaging data generated provides powerful information on targeting, clearance and biodistribution of the product, which aids in early drug development. This de-risks the development process and allows making early decisions regarding biopharmaceutical drug candidates. Clarity offers this capability as a service to biopharmaceutical developers worldwide and also utilises the expertise to develop its own clinical pipeline.